Abstract:Significance: Pathologic scarring occurs secondary to imbalances in the cellular mechanisms of wound healing and affects millions of people annually. This review article aims to provide a concise overview of the pathophysiology and management of pathologic scarring for clinicians and scientists alike. Recent Advances: Contemporary research in the field has identified aberrations in transforming growth factor-β/small mothers against decapentaplegic (TGF-β/SMAD) signaling pathways as key drivers of pathologic scar formation; indeed, this pathway is targeted by many treatment modalities and translational investigations currently underway. Although intralesional injection of corticosteroids has been the gold standard in the treatment of pathologic scarring, studies show greater treatment efficacy with the use of combination injections such as triamcinolone/5-fluorouracil and triamcinolone/botulinum toxin. Adjunctive therapies including ablative fractional carbon dioxide/erbium-doped yttrium aluminum garnet and non-ablative pulsed-dye lasers, microneedling, and carboxytherapy have shown encouraging results in small cohort studies. Translational investigations involving the use of nanogels, RNA interference, and small molecules targeting TGF-β/SMAD pathways are also currently underway and hold promise for the future. Critical Issues: The heterogeneous nature of hypertrophic scars and keloids poses significant challenges in formulating standardized treatment and assessment protocols, thereby limiting the conclusions that can be drawn. Future Directions: Rigorous clinical trials into the individual and synergistic effects of these therapies would be ideal before any definitive conclusions or evidence-based treatment recommendations can be made. Owing to the heterogeneity of the pathology and patient population, well-conducted cohort studies may be the next best option.

Inflammation in Wound Healing and Pathological Scarring

The Roles of Inflammation in Keloid and Hypertrophic Scars

Role of Inflammasomes in Keloids and Hypertrophic Scars—Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis

The Pathophysiology and Management of Pathologic Scarring-a Contemporary Review

Keloids and hypertrophic scars: update and future directions.

[Research Advances on the Role and Mechanism of Inflammatory Response in the Formation of Hypertrophic Scars and Keloids].

Toward understanding scarless skin wound healing and pathological scarring

Direct And Indirect Roles Of Macrophages In Hypertrophic Scar Formation

Systemic factors that shape cutaneous pathological scarring

The role of macrophages in the formation of hypertrophic scars and keloids

Advances in the Modulation of Cutaneous Wound Healing and Scarring

Therapeutic Strategies by Regulating Interleukin Family to Suppress Inflammation in Hypertrophic Scar and Keloid

Endothelial Dysfunction and Mechanobiology in Pathological Cutaneous Scarring: Lessons Learned from Soft Tissue Fibrosis

Immunological Mechanisms of Scarring and Their Psychological Impact on Patients.

Macrophage Polarization: A Novel Target and Strategy for Pathological Scarring

Acne-induced pathological scars: pathophysiology and current treatments

An Update on Molecular Mechanisms of Scarring—A Narrative Review

Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation

Epithelial–mesenchymal transition in the formation of hypertrophic scars and keloids

Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing

Comprehensive Modular Analyses of Scar Subtypes Illuminate Underlying Molecular Mechanisms and Potential Therapeutic Targets.